Full-Time

Translational Medicine, Precision Medicine

Updated on 11/26/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Entry

Cambridge, MA, USA

Requires on-site presence in Cambridge, MA for at least 50% of the time.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Understanding of oncology, biomarkers, polymerase chain-reaction and next-generation sequencing technology
  • Excellent communication skills, both written and verbal are required
  • Deliver quality work in a timely manner
  • Ability to work following defined process and instructions
  • Highly organized and meticulous
  • Ability to work on-site in Cambridge, MA at least 50% time
  • Knowledge on information storage and inquiry using excel is a strong plus
  • Flexibility with can-do attitude
Responsibilities
  • Works under supervision of Senior Director / Director of Precision Medicine
  • Participates in cross functional team meetings for the development, execution, and implementation of the precision medicine team strategy
  • Conducts data mining of public domain to help characterize performance metrics of diagnostic laboratory tests used by clinical trial sites
  • Compiles new information and evaluate existing information within an existing database to refine and aggregate data about lab tests used by clinical sites
  • Monitors database to ensure timely and accurate entry of required content
  • Proposes opportunities to improve the effectiveness and efficiency of the system and workflow to track lab tests

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing access to effective and affordable healthcare solutions.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?